Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00681356 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy Study of 4975 in Patients Undergoing Total Knee Replacement
A Phase 3 study of Total Knee Arthroplasty (Replacement), sponsored by Anesiva.
- Completed
- Registry status
- Phase 3
- Development phase
- 214
- Enrollment target
- 20
- Study locations
NCT00681356 is a Phase 3 study of Total Knee Arthroplasty (Replacement) that has completed, run by Anesiva. The registered enrollment target is 214 participants. The trial reports 20 study locations across 9 states.
The verdict
NCT00681356, a Phase 3 study of Total Knee Arthroplasty (Replacement), has completed, sponsored by Anesiva.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 214 participants
- Enrollment target
- 20
- Study locations
Study Summary
Evaluate the efficacy, tolerability, safety, and pharmacokinetics of 4975 in patients undergoing total knee replacement
Conditions Studied
Interventions
- DRUG Placebo Comparator
- DRUG 4975, 15 and 5 mg
- DRUG 4975 - 5 mg
Study Locations (20)
California
- Glendale Adventist Medical Center - Lotus Clinical Research - Glendale
- Physicians Clinical Research Corporation - Laguna Hills
- Saddleback Memorial Medical Center/Accurate Clinical Trials - Laguna Hills
- Webster Orthopeadic Medical Group - Oakland
- UCSF-Mt. Zion Medical Center - San Francisco
Florida
- Florida Hospital - Florida Research Associates, LLC - DeLand
- University of Miami, Miller School of Medicine - Miami
- Miami Institute for Medical Research - Miami
- Southeastern Clinical Research Consultants - Orlando
- Coastal Medical Research - Port Orange
Alabama
- Alabama Clinical Therapeutics, LLC - Birmingham
- Springhill Medical Center - Mobile
- Hellen Keller Hospital - Sheffield
Michigan
- William Beaumont Hospital - Royal Oak
- William Beaumont Hospital - Troy
Arizona
- Visions Clinical Research/Tucson Medical Center - Tucson
Connecticut
- Orthopedic Associates of Hartford - Hartford
Illinois
- Rush University Medical Center - Chicago
Maryland
- Ruxton Professional Center - Orthopaedic Associates - Towson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2007-09 |
| Est. Completion | 2008-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00681356
The ClinicalTrials.gov registry entry for NCT00681356 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 214 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Anesiva, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Total Knee Arthroplasty (Replacement) appearing as the primary indexed condition, and to 3 interventions - of which Placebo Comparator is the first listed.
NCT00681356 reports 20 study locations spanning 9 distinct geographic areas - top geographies include California, Florida, Alabama.
Frequently Asked Questions
What is clinical trial NCT00681356 about?
NCT00681356 is a clinical study titled "Safety and Efficacy Study of 4975 in Patients Undergoing Total Knee Replacement". Evaluate the efficacy, tolerability, safety, and pharmacokinetics of 4975 in patients undergoing total knee replacement
What is the current status of trial NCT00681356?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 214 participants. The study started on 2007-09. Estimated completion is 2008-12.
What conditions does trial NCT00681356 study?
This clinical trial studies the following conditions: Total Knee Arthroplasty (Replacement).
What interventions are being tested in trial NCT00681356?
The interventions under investigation include: Placebo Comparator (DRUG), 4975, 15 and 5 mg (DRUG), 4975 - 5 mg (DRUG).
Who is sponsoring clinical trial NCT00681356?
This trial is sponsored by Anesiva, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00681356 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.